Clinical Trial Update: Evaluation of Long Term Safety of Tesofensine in Patients With Obesity [Phase 2]

View source ↗

Summary

Phase 2 safety-focused trial update evaluating long-term safety of Tesofensine in obesity patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Tesofensine (tesofensine)

Snippet

Sponsor: NeuroSearch A/S | Conditions: Obesity | Phase 2 | Status: COMPLETED